Document ID: chunk:federal_register_of_legislation:F2022C00898:front:0:p7
Version: federal_register_of_legislation:F2022C00898
Segment Type: other
Provision Reference: 
Character Range: 17335–19568

worsening of diabetes mellitus;
(h)          having infection with hepatitis C virus before the clinical worsening of diabetes mellitus;
(i)            having hypertension at the time of the clinical worsening of diabetes mellitus;
(j)            having chronic renal failure at the time of the clinical worsening of diabetes mellitus;
             Note: chronic renal failure is defined in the Schedule 1 - Dictionary.
(k)          having gout or hyperuricaemia at the time of the clinical worsening of diabetes mellitus;
             Note: hyperuricaemia is defined in the Schedule 1 - Dictionary.
(l)            having posttraumatic stress disorder at the time of the clinical worsening of diabetes mellitus;
(m)        having bilateral orchiectomy before the clinical worsening of diabetes mellitus;
(n)          having anti-androgen therapy as specified for at least the one year before the clinical worsening of diabetes mellitus;
             Note: anti-androgen therapy as specified is defined in the Schedule 1 - Dictionary.
(o)          being exposed to arsenic as specified before the clinical worsening of diabetes mellitus; or
             Note: being exposed to arsenic as specified is defined in the Schedule 1 - Dictionary.
(p)          inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD):
(i)            for a cumulative period of at least 500 hours, within a consecutive period of ten years before the clinical worsening of diabetes mellitus; and
(ii)         where the first exposure occurred at least five years before the clinical worsening of diabetes mellitus; and
(iii)       where that exposure has ceased, the clinical worsening of diabetes mellitus has occurred within 25 years of cessation;
               Note: inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) is defined in the Schedule 1 - Dictionary.
(24)      for gestational diabetes mellitus and type 2 diabetes mellitus only, being pregnant at the time of the clinical worsening of diabetes mellitus;
(25)      inability to obtain appropriate clinical management for diabetes mellitus.